Andrea Sikon, MD The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician
Holly L. Thacker, MD Director, The Women’s Health Center at the Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, and Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation; Certified North American Menopause Society Menopause Clinician
Address: Holly L. Thacker, MD, FACP, Women’s Health Center at the Gault Women’s Health and Breast Pavilion, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail thackeh@ccf.org
This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTAlthough alternatives exist, hormone therapy remains the most effective treatment for menopausal symptoms such as hot flashes, and it is the only treatment approved by the US Food and Drug Administration (FDA) for this indication. The FDA recommends using the lowest effective dose of hormones. New low-dose preparations and new dosage forms of hormone therapy are available.
